Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNARE complex proteins are a family of membrane-associated proteins that mediate the fusion of synaptic vesicles with the presynaptic membrane at the neuromuscular junction, enabling neurotransmitter (acetylcholine) release and subsequent muscle contraction[3][4][5][6][7]. The core neuronal SNARE complex comprises synaptobrevin (on vesicle), syntaxin, and SNAP-25 (on plasma membrane), forming a four-helix bundle that brings the vesicle and target membranes together to permit fusion and exocytosis[4][5][6][7]. SNARE dysfunction leads to severe neuromuscular disease and is targeted by toxins such as botulinum and tetanus to induce paralysis[7]. SNARE proteins in this context are not a single molecule but a required multi-protein machinery essential for normal nervous system function and also a validated therapeutic target for certain neurotoxins[3][7].
Inhibition of neurotransmitter release via cleavage of specific SNARE proteins (by neurotoxins); potential for small molecule inhibitors or modulators (still largely experimental)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNARE complex protein (SNARE).